Valuation: Biosenta Inc.

Market Cap 1.29M 922K 798K 744K 684K 87.62M 1.31M 8.74M 3.43M 43.84M 3.46M 3.38M 145M P/E 2024
-1.19x
P/E 2025 -1.59x
Enterprise Value 7.9M 5.64M 4.88M 4.55M 4.18M 536M 7.99M 53.46M 20.98M 268M 21.16M 20.7M 888M EV / Sales 2024
6,101x
EV / Sales 2025 8,809x
Free-Float
88.05%
Yield 2024 *
-
Yield 2025 -
1 day-50.00%
1 month-22.22%
3 months-41.67%
6 months-56.25%
Current year-65.00%
1 month 0.01
Extreme 0.01
0.08
Current year 0.01
Extreme 0.01
0.12
1 year 0.01
Extreme 0.01
0.15
3 years 0.01
Extreme 0.01
0.89
5 years 0.01
Extreme 0.01
0.89
10 years 0
Extreme 0
2.5
Manager TitleAgeSince
Chief Executive Officer - 16/07/2019
Director TitleAgeSince
Chairman 90 16/07/2019
Director/Board Member - 05/10/2011
Chairman 65 17/02/2015
Date Insider Type Main position Quantity % Market Cap.
3/3/26 A Option

Chairman

60,000 0.1741%
12/30/25 A Option 133,977 0.4201%
12/29/25 A Option 90,632 0.2842%
Change 5-day change 1-year change 3-year change Capi.($)
-50.00%-.--%-75.00%-91.25% 918K
+1.33%-1.07%-7.46%-8.78% 45.02B
+0.62%+3.79%+13.72%+9.52% 24.43B
+1.12%+6.23%-15.58%-35.47% 12.66B
+1.71%+4.12%+20.70%-4.80% 5.55B
+1.37%+8.85%+2.50%-50.67% 3.84B
-0.51%+5.58%+8.17%+4.39% 3.17B
+2.89%-1.46%+14.96%+25.35% 2.96B
-0.91%+1.87%+3.61%+64.01% 1.35B
-0.19%-2.29%+3.71%+826.12% 882M
Average -4.26%-0.78%-3.07%+73.84% 9.98B
Weighted average by Cap. +1.10%+1.57%+0.05%+0.71%

Financials

2024 2025
Net sales 1.38K 983.71 851.99 794.21 730.46 93.54K 1.39K 9.33K 3.66K 46.8K 3.69K 3.61K 155K 1.21K 863.86 748.19 697.45 641.47 82.14K 1.22K 8.2K 3.22K 41.1K 3.24K 3.17K 136K
Net income -2.23M -1.59M -1.38M -1.28M -1.18M -151M -2.25M -15.08M -5.92M -75.6M -5.97M -5.84M -250M -2.51M -1.79M -1.55M -1.44M -1.33M -170M -2.53M -16.96M -6.66M -85.05M -6.71M -6.57M -282M
Net Debt 5.54M 3.95M 3.42M 3.19M 2.94M 376M 5.61M 37.52M 14.72M 188M 14.85M 14.52M 623M 6.61M 4.71M 4.08M 3.81M 3.5M 448M 6.68M 44.72M 17.55M 224M 17.7M 17.31M 743M
Logo Biosenta Inc.
Biosenta Inc. is engaged in developing, producing, and manufacturing an array of chemical compounds for household and industrial applications, utilizing advanced encapsulated nanotechnology. It develops antimicrobial products that offer environmentally friendly solutions to a global market. Its flagship product, Tri-Filler, represents an antimicrobial technology, providing durable protection against a wide spectrum of bacteria, molds, and fungi. Tri-filler's Nano-technology particles provide anti-microbial protection while preventing the growth of mold, bacteria and viruses. Tri-filler can be embedded to protect various materials, including drywall, plastic and resin, from microbe formation. These compounds remain active for decades and protect the drywall of buildings, objects such as resin furniture, carpet rubber backing and synthetic tufts containing plastic, resin, textiles and others. Its true disinfectant is recognized by Health Canada for use in the fight against COVID-19.
Employees
-
Date Price Change Volume
29/07/26 CA$0.0350 -50.00% 8,500
28/07/26 CA$0.0700 -6.67% 2,000